STAT

STAT+: Pharmalittle: We’re reading about an Amgen drug for lung cancer, a Novo plant fire, and more

The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up,, , , and . And what about you? Once again, we will maintain this is a fine time to enjoy the great outdoors. You could also plan a summer getaway or take a moment to tidy up around your castle. Or simply plan the rest of your life. Whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Abortion Pill Access, Employer Coverage Of GLP-1 Drugs And More
Updates from the Pharmalittle newsletter campus: —FDA advised drugmakers to update Covid vaccines to target the KP.2 strain —Leadership from Done startup were arrested and charged with fraud —U.S. authorities…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Docs Paid For Endorsements, Novartis Suing Maryland, And Lots More
In today's Pharmalittle roundup, we're reading about docs paid for endorsements, Novartis suing Maryland, and lots more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About The Cencora Data Breach, A Failed Pandemic Treaty, And More
Almost a dozen pharmaceutical companies have lost sensitive customer data due to a supply chain cyberattack that trickled down from Cencora.

Related Books & Audiobooks